IMC Chicago LLC Acquires 10,209 Shares of ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS)

IMC Chicago LLC raised its holdings in shares of ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) by 68.1% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 25,210 shares of the company’s stock after purchasing an additional 10,209 shares during the period. IMC Chicago LLC owned 11.46% of ProShares UltraShort Nasdaq Biotechnology worth $443,000 at the end of the most recent reporting period.

ProShares UltraShort Nasdaq Biotechnology Stock Performance

Shares of NASDAQ BIS opened at $16.65 on Friday. The firm has a fifty day simple moving average of $17.84 and a two-hundred day simple moving average of $18.03. ProShares UltraShort Nasdaq Biotechnology has a 12 month low of $15.99 and a 12 month high of $26.51.

ProShares UltraShort Nasdaq Biotechnology Cuts Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 3rd. Shareholders of record on Wednesday, June 26th will be given a dividend of $0.1612 per share. The ex-dividend date is Wednesday, June 26th. This represents a $0.64 annualized dividend and a yield of 3.87%.

ProShares UltraShort Nasdaq Biotechnology Company Profile

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks investment results for a single day only, not for longer periods. The Fund seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from twice (200%) the return of the Nasdaq Biotechnology Index (the Index) for that period.